Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 USD | +1.33% | 0.00% | -89.40% |
Apr. 16 | Calidi Biotherapeutics Prices $6.1 Million Offering | MT |
Mar. 21 | H.C. Wainwright Lowers Price Target on Calidi Biotherapeutics to $2 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-89.40% | 8.12M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- CLDI Stock
- News Calidi Biotherapeutics, Inc.
- First Light Acquisition Group Shareholders Approve Merger Date Extension; Tom Vecchiolla Named Co-CEO